Dorene Markel
Manage Your Profile
About
BIO
Senior Advisor, Mary Tyler Moore Vision Initiative
Ms. Markel has been the Senior Advisor to the Mary Tyler Moore Vision Initiative since July 2024 after serving as the founding Managing Director for the previous two years. As the Managing Director, she worked with Dr. Levine and the leadership team to create the Mary Tyler Moore Vision Initiative and launch its platform programs.
Ms. Markel brings extensive experience to her roles from four decades of leadership service at the University of Michigan (UM), with specialized expertise in creating and managing clinical research and diabetes initiatives. Her past achievements include: working with Dr. Francis Collins to create the NIH-funded UM Human Genome Center and serving as the Center’s Human Studies Core Director; serving as the Administrative Director of the NIH-funded UM General Clinical Research Center; as founding Administrative Director of the Center for the Advancement of Clinical Research; as founding Administrative Director of the NIH-funded Michigan Institute for Clinical and Health Research; and as the first Director for Clinical and Translational Research for the UM Medical School. She was the founding Director of the Brehm Center for Diabetes Research and manager of the Brehm Coalition; founding Managing Director of M-Diabetes; and founding Managing Director of the Elizabeth Weiser Caswell Diabetes Institute. Ms. Markel retired from UM in 2022 and retains an active emeritus faculty position in the UM Department of Learning Health Sciences. She has extensive experience in ethical and regulatory issues in human research having served on the Michigan Medicine and Castle IRBs. Ms. Markel received her B.S. from Michigan Technological University in Biological Sciences; her M.S. from the University of Michigan Medical School, Department of Human Genetics, specializing in Genetic Counseling; and her M.H.S.A (Health Services Administration) degree from the University of Michigan School of Public Health, Department of Health Management and Policy.
Links
Mary Tyler Moore Vision Initiative
Qualifications
-
Master of Health Services Administration, Health Services AdministrationUniversity of Michigan–Ann Arbor, Ann Arbor, United States
1988 - 1991
-
Master of Science, Human Genetics/Genetic CounselingUniversity of Michigan Medical School, Ann Arbor, United States
1982 - 1983
-
Bachelors Degree: Biological Sciences, Biological SciencesMichigan Technological University, Houghton, United States
1979 - 1981
Center Memberships
-
Center MemberCenter for History, Humanities, Arts, Social Sciences and Ethics in Medicine
-
Center MemberCenter for Global Health Equity
Research Overview
Diabetes Complications
Diabetic Retinal Disease
Ethical issues in human genetic research
Recent Publications
-
Sampani K, Fickweiler W, Markel DS, Faulkner L, Vujosevic S, Peto T, Meyerhoffer O, Eydelman M, Levine SR, Sun JK, Gardner TW, Abramoff MD. Progress in Retinal and Eye Research, 2026 Jul 1; 113:Journal ArticleDiabetic retinal disease cure accelerator: Modernizing staging and endpoints
DOI:10.1016/j.preteyeres.2026.101485 -
Levine SR, Markel DS, Myers MG, Barunas R, Sun JK, Chang DS, Maguire MG, Vujosevic S, Fort PE, Atkinson M, Baschiera F, Gates C, Hunt JM, King GL, Kretzler M, Lai P, Lewis D, Luhmann UFO, McLeod S, Oxenreiter C, Unsworth S, Chambers W, Aiello LP, Ehrlich J, German CL, Tadayoni R, Wolf RM, Silva P, Carlson E, Gott B, Oxenreiter M, Sexton N, Das A, Gardner TW. Translational Vision Science and Technology, 2025 Jul 1; 14 (7):Journal ArticleReport of the 2023 Mary Tyler Moore Vision Initiative Workshop
DOI:10.1167/tvst.14.7.11 PMID: 40679331 -
Fickweiler W, Sampani K, Markel DS, Levine SR, Sun JK, Gardner TW. Translational Vision Science and Technology, 2025 May 1; 14 (5):Journal ArticleAdvancing Toward a World Without Vision Loss From Diabetes: Insights From The Mary Tyler Moore Vision Initiative Symposium 2024 on Curing Vision Loss From Diabetes
DOI:10.1167/tvst.14.5.12 PMID: 40338731 -
Domalpally A, Fickweiler W, Levine SR, Goetz KE, Vanderbeek BL, Lee A, Sundstrom JM, Markel D, Sun JK. Translational Vision Science and Technology, 2024 Oct 1; 13 (10):Journal ArticleData Harmonization, Standardization, and Collaboration for Diabetic Retinal Disease (DRD) Research: Report From the 2024 Mary Tyler Moore Vision Initiative Workshop on Data
DOI:10.1167/tvst.13.10.4 PMID: 39361314 -
Levine SR, Myers MG, Barunas R, Chang DS, Dutta S, Maddess T, Liebmann JM, Sherman S, Eydelman M, Sun JK, Chambers W, Wickström K, Luhmann UFO, Pallinat M, Glassman A, Aiello LP, Markel DS, Gardner TW. Translational Vision Science and Technology, 2023 Nov 1; 12 (11):Journal ArticleReport From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop
DOI:10.1167/tvst.12.11.33 PMID: 38015167 -
Griauzde DH, Othman A, Dallas C, Oshman L, Gabison J, Markel DS, Richardson CR, Kullgren JT, Piatt G, Heisler M, Kilbourne A, Kraftson A. Primary Health Care Research & Development, 2022 Sep 21; 23:Journal ArticleDeveloping a Weight Navigation Program to Support Personalized and Effective Obesity Management in Primary Care Settings: Protocol for a Quality Improvement Program with an Embedded Single-Arm Pilot Study
DOI:10.1017/S1463423621000906 -
Griauzde DH, Othman A, Dallas C, Oshman L, Gabison J, Markel DS, Richardson CR, Kullgren JT, Piatt G, Heisler M, Kilbourne AM, Kraftson A. Primary health care research & development, 2022 Mar; 23:Journal ArticleDeveloping a Weight Navigation Program to support personalized and effective obesity management in primary care settings: protocol for a quality improvement program with an embedded single-arm pilot study
-
Shah AR, Van Horn AN, Verchinina L, Wichorek M, Su L, Markel D, Gardner TW. Ophthalmology Retina, 2019 Jan 1; 3 (5): 410 - 416.Journal ArticleBlood Pressure is Associated with Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Treatment in Patients with Diabetes